Collecting real-world data on treatments for brain aneurysms
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial is gathering information from patients who are getting a standard treatment for a brain aneurysm using MicroVention devices. It helps doctors understand how well these treatments work in real life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have one brain aneurysm (either burst or unburst) that your doctor plans to treat with a procedure inside the blood vessels.
- Your doctor has already decided to use a MicroVention device as the main treatment tool.
- You or a legal representative can sign a consent form before or within 48 hours after emergency treatment.
- Your doctor thinks you can attend all the follow-up visits needed for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device to block blood flow into unruptured brain aneurysms (balloon-like bulges). It is for adults whose aneurysm has not bled and fits specific size requirements. The goal is to see if the device is safe and works well.
This trial tests a new device, called LuSeed, for treating brain aneurysms that haven't burst. The device is placed inside the aneurysm to block blood flow and prevent rupture. The study aims to see if the device is safe and works well in patients with a specific type of aneurysm.
This study collects information from routine medical care to learn how well MicroVention devices work in real-world settings for people being treated for brain aneurysms or stroke from a blocked artery. Your doctor has already decided to use one of these devices as part of your standard treatment.
This trial tests a new device that is placed inside a brain aneurysm to block blood flow and prevent it from bursting. It may be an option for people with a single brain aneurysm that has not been treated yet.
This study collects information from patients in France who are being treated for a brain aneurysm with specific flow diversion devices (p64, p48 MW, or p64 MW). The goal is to confirm that these devices are safe and work well in real-world use, which can help doctors make better treatment decisions.
This trial studies an in-the-aneurysm device placed through a blood vessel to treat certain wide-neck brain aneurysms. It may help prevent aneurysm complications and reduce the risk of needing other procedures, but eligibility depends heavily on your aneurysm shape and health.
Hear when a new Aneurysm Cerebral trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.